Cargando…
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma
BACKGROUND: Flat epithelial atypia (FEA) of the breast is characterised by a few layers of mildly atypical luminal epithelial cells. Genetic changes found in ductal carcinoma in situ (DCIS) and invasive ductal breast cancer (IDC) are also found in FEA, albeit at a lower concentration. So far, miRNA...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695476/ https://www.ncbi.nlm.nih.gov/pubmed/19473551 http://dx.doi.org/10.1186/1471-2407-9-163 |
_version_ | 1782168200769699840 |
---|---|
author | Qi, Liqiang Bart, Joost Tan, Lu Ping Platteel, Inge Sluis, Tineke van der Huitema, Sippie Harms, Geert Fu, Li Hollema, Harry Berg, Anke van den |
author_facet | Qi, Liqiang Bart, Joost Tan, Lu Ping Platteel, Inge Sluis, Tineke van der Huitema, Sippie Harms, Geert Fu, Li Hollema, Harry Berg, Anke van den |
author_sort | Qi, Liqiang |
collection | PubMed |
description | BACKGROUND: Flat epithelial atypia (FEA) of the breast is characterised by a few layers of mildly atypical luminal epithelial cells. Genetic changes found in ductal carcinoma in situ (DCIS) and invasive ductal breast cancer (IDC) are also found in FEA, albeit at a lower concentration. So far, miRNA expression changes associated with invasive breast cancer, like miR-21, have not been studied in FEA. METHODS: We performed miRNA in-situ hybridization (ISH) on 15 cases with simultaneous presence of normal breast tissue, FEA and/or DCIS and 17 additional cases with IDC. Expression of the miR-21 targets PDCD4, TM1 and PTEN was investigated by immunohistochemistry. RESULTS: Two out of fifteen cases showed positive staining for miR-21 in normal breast ductal epithelium, seven out of fifteen cases were positive in the FEA component and nine out of twelve cases were positive in the DCIS component. A positive staining of miR-21 was observed in 15 of 17 IDC cases. In 12 cases all three components were present in one tissue block and an increase of miR-21 from normal breast to FEA and to DCIS was observed in five cases. In three cases the FEA component was negative, whereas the DCIS component was positive for miR-21. In three other cases, normal, FEA and DCIS components were negative for miR-21 and in the last case all three components were positive. Overall we observed a gradual increase in percentage of miR-21 positive cases from normal, to FEA, DCIS and IDC. Immunohistochemical staining for PTEN revealed no obvious changes in staining intensities in normal, FEA, DCIS and IDC. Cytoplasmic staining of PDCD4 increased from normal to IDC, whereas, the nuclear staining decreased. TM1 staining decreased from positive in normal breast to negative in most DCIS and IDC cases. In FEA, the staining pattern for TM1 was similar to normal breast tissue. CONCLUSION: Upregulation of miR-21 from normal ductal epithelial cells of the breast to FEA, DCIS and IDC parallels morphologically defined carcinogenesis. No clear relation was observed between the staining pattern of miR-21 and its previously reported target genes. |
format | Text |
id | pubmed-2695476 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26954762009-06-12 Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma Qi, Liqiang Bart, Joost Tan, Lu Ping Platteel, Inge Sluis, Tineke van der Huitema, Sippie Harms, Geert Fu, Li Hollema, Harry Berg, Anke van den BMC Cancer Research Article BACKGROUND: Flat epithelial atypia (FEA) of the breast is characterised by a few layers of mildly atypical luminal epithelial cells. Genetic changes found in ductal carcinoma in situ (DCIS) and invasive ductal breast cancer (IDC) are also found in FEA, albeit at a lower concentration. So far, miRNA expression changes associated with invasive breast cancer, like miR-21, have not been studied in FEA. METHODS: We performed miRNA in-situ hybridization (ISH) on 15 cases with simultaneous presence of normal breast tissue, FEA and/or DCIS and 17 additional cases with IDC. Expression of the miR-21 targets PDCD4, TM1 and PTEN was investigated by immunohistochemistry. RESULTS: Two out of fifteen cases showed positive staining for miR-21 in normal breast ductal epithelium, seven out of fifteen cases were positive in the FEA component and nine out of twelve cases were positive in the DCIS component. A positive staining of miR-21 was observed in 15 of 17 IDC cases. In 12 cases all three components were present in one tissue block and an increase of miR-21 from normal breast to FEA and to DCIS was observed in five cases. In three cases the FEA component was negative, whereas the DCIS component was positive for miR-21. In three other cases, normal, FEA and DCIS components were negative for miR-21 and in the last case all three components were positive. Overall we observed a gradual increase in percentage of miR-21 positive cases from normal, to FEA, DCIS and IDC. Immunohistochemical staining for PTEN revealed no obvious changes in staining intensities in normal, FEA, DCIS and IDC. Cytoplasmic staining of PDCD4 increased from normal to IDC, whereas, the nuclear staining decreased. TM1 staining decreased from positive in normal breast to negative in most DCIS and IDC cases. In FEA, the staining pattern for TM1 was similar to normal breast tissue. CONCLUSION: Upregulation of miR-21 from normal ductal epithelial cells of the breast to FEA, DCIS and IDC parallels morphologically defined carcinogenesis. No clear relation was observed between the staining pattern of miR-21 and its previously reported target genes. BioMed Central 2009-05-28 /pmc/articles/PMC2695476/ /pubmed/19473551 http://dx.doi.org/10.1186/1471-2407-9-163 Text en Copyright ©2009 Qi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Qi, Liqiang Bart, Joost Tan, Lu Ping Platteel, Inge Sluis, Tineke van der Huitema, Sippie Harms, Geert Fu, Li Hollema, Harry Berg, Anke van den Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title_full | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title_fullStr | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title_full_unstemmed | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title_short | Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
title_sort | expression of mir-21 and its targets (pten, pdcd4, tm1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695476/ https://www.ncbi.nlm.nih.gov/pubmed/19473551 http://dx.doi.org/10.1186/1471-2407-9-163 |
work_keys_str_mv | AT qiliqiang expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT bartjoost expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT tanluping expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT platteelinge expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT sluistinekevander expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT huitemasippie expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT harmsgeert expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT fuli expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT hollemaharry expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma AT bergankevanden expressionofmir21anditstargetsptenpdcd4tm1inflatepithelialatypiaofthebreastinrelationtoductalcarcinomainsituandinvasivecarcinoma |